Antiplatelet therapy before, during, and after extremity revascularization

被引：9

作者：

Yang, Jane K. ^{[1
]}

Jimenez, Juan Carlos ^{[1
]}

Jabori, Sinan ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Div Vasc Surg, Los Angeles, CA 90095 USA

来源：

JOURNAL OF VASCULAR SURGERY | 2014年 / 60卷 / 04期

关键词：

AMERICAN-COLLEGE; CLOPIDOGREL; METAANALYSIS; ANGIOPLASTY; PREVENTION; THROMBOSIS; ASPIRIN; DISEASE; GRAFTS;

D O I：

10.1016/j.jvs.2014.07.006

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Peripheral arterial disease (PAD) is well recognized as a marker for systemic atherosclerosis. Platelets play an essential role in all stages of the disease, contributing to both thrombosis and the development of atherosclerosis. Medication regimens to optimize outcomes in both patients who are to undergo revascularization and those who will be managed without interventional therapy must address antiplatelet therapy. Given the common cardiovascular and cerebrovascular comorbidities in patients with PAD, antiplatelet therapy has the potential to decrease thromboembolic events in addition to improving patency after interventions. This clinical update reviews the current literature and recommendations for antiplatelet therapy in patients with PAD.

引用

页码：1085 / 1091

页数：7

共 33 条

[21]

Mitchell R.N., 2010, ROBBINS COTRANS PATH, P115

[22]

Poskitt K R, 1991, Eur J Vasc Surg, V5, P541, DOI 10.1016/S0950-821X(05)80342-1

[23] Treatment Options for Patients With Poor Clopidogrel Response [J].

Roberts, Daniela I. ;

Nawarskas, James J. .

CARDIOLOGY IN REVIEW, 2013, 21 (06) :309-317

[24] Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia [J].

Romiti, Marcello ;

Albers, Maximiano ;

Brochado-Neto, Francisco Cardoso ;

Durazzo, Anai Espinelli S. ;

Pereira, Carlos Alberto Bragan A. ;

De Luccia, Nelson .

JOURNAL OF VASCULAR SURGERY, 2008, 47 (05) :975-981

[25] THE EFFICACY OF DEXTRAN-40 IN PREVENTING EARLY POSTOPERATIVE THROMBOSIS FOLLOWING DIFFICULT LOWER-EXTREMITY BYPASS [J].

RUTHERFORD, RB ;

JONES, DN ;

BERGENTZ, SE ;

BERGQVIST, D ;

KARMODY, AM ;

DARDIK, H ;

MOORE, WS ;

GOLDSTONE, J ;

FLINN, WR ;

COMEROTA, AJ ;

FRY, WJ ;

SHAH, DM .

JOURNAL OF VASCULAR SURGERY, 1984, 1 (06) :765-773

[26] Review of Prasugrel for the Secondary Prevention of Atherothrombosis [J].

Spinler, Sarah A. ;

Rees, Catherine .

JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (05) :383-395

[27] Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery [J].

Stone, David H. ;

Goodney, Philip P. ;

Schanzer, Andres ;

Nolan, Brian W. ;

Adams, Julie E. ;

Powell, Richard J. ;

Walsh, Daniel B. ;

Cronenwett, Jack L. .

JOURNAL OF VASCULAR SURGERY, 2011, 54 (03) :779-784

[28]

Tangelder MJD, 2000, LANCET, V355, P346

[29] Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication [J].

Thompson, PD ;

Zimet, R ;

Forbes, WP ;

Zhang, P .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (12) :1314-1319

[30]

VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801

← 1 2 3 4 →